Legal Opinion

Boehringer Ingelheim International GmbH v. Barr Laboratories, Inc.

Court of Appeals for the Federal Circuit

Decided January 25, 2010No. 2009-1032Published

1Opinion of the Court

592 F.3d 1340 (2010)

BOEHRINGER INGELHEIM INTERNATIONAL GMBH and Boehringer Ingelheim Pharmaceuticals, Inc., Plaintiffs-Appellants,

v.

BARR LABORATORIES, INC. and Barr Pharmaceuticals, Inc., Defendants, and

Mylan Pharmaceuticals, Inc., Defendant-Appellee.

No. 2009-1032.

United States Court of Appeals, Federal Circuit.

January 25, 2010.

Bruce M. Wexler, Paul, Hastings, Janofsky & Walker LLP, of New York, NY, argued for plaintiffs-appellants. With him on the brief were Joseph M. O'Malley, Jr., Eric W. Dittmann and Angela C. Ni; and Stephen B. Kinnaird, of Washington, DC.

Shannon M. Bloodworth, Perkins…

Also in this document: Dissent.

2Cases cited22 opinions

  1. Ntp, Inc. v. Research in Motion, Ltd.Court of Appeals for the Federal Circuit · 2005
  2. Amgen Inc. v. F. Hoffmann-La Roche Ltd.Court of Appeals for the Federal Circuit · 2009
  3. Symbol Technologies, Inc. v. Opticon, Inc., and Opto ElectronicsCourt of Appeals for the Federal Circuit · 1991
  4. Nicholas v. Perricone, M.D. v. Medicis Pharmaceutical Corporation, Defendant-CrossCourt of Appeals for the Federal Circuit · 2005
  5. In Re Paolo LongiCourt of Appeals for the Federal Circuit · 1985

17 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API